Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies;Therapeutische strategien bei lokoregionalen rezidiven gastrointestinaler tumoren: Palliation oder kuration?

Chirurg

Volumn 77, Issue 3, 2006, Pages 227-235

  Siewert, J ^a   Lordick, F ^a   Ott, K ^a   Brucher B ^a   Rosenberg, R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Curative; Gastrointestinal tumors; Local relapse; Palliative; Second resection

Indexed keywords

ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; GASTROINTESTINAL TUMOR; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; REOPERATION; REVIEW; TUMOR RECURRENCE;

COMBINED MODALITY THERAPY; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PALLIATIVE CARE; PROGNOSIS; REOPERATION;

EID: 33645074925     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-006-1163-x     Document Type: Review

References (41)

1. Adam IJ, Mohamdee MO, Martin IG et al. (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344: 707
2. Bedrosian I, Giacco G, Pederson L et al. (2005) Outcome after curative Resection for locally recurrent rectal cancer. Dis Colon Rectum 49: 1
3. Bell SW, Walker KG, Rickard MJFX et al. (2003) Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg 90: 1261
4. Bennett JJ, Gonen M, D'Angelica M, Jaques DP, Brennan MF, Coit DG (2005) Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg 201: 503
5. Birbeck KF, Macklin CP, Tiffin NJ et al. (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235: 449
6. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I (2005) Surgery for Locally Recurrent Rectal Cancer. Dis Colon Rectum 48: 929
7. Bozzetti F, Bertario L, Rossetti C et al. (1997) Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 40: 1421
8. Brücher BLDM, Wieder H, Lordick F et al. (2006) Final report of assessment of response to neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma patients by 18 FDG-PET. ASCO GI Symposium, San Francisco, USA January 2006 (Abstr. ID 64)
9. Brücher BLDM, Becker K, Lordick F et al. (2006) Histopathological response by residual tumor cells in patients with neoadjuvant treated esophageal squamous cell carcinomas. Cancer, in press
10. Brücher BLDM, Stein Hu, Werner, Siewert JR (2001) Lymphatic vessel infiltration as an independent prognostic factor in primary rejected esophageal squamous cell carcinoma. Cancer 92(8): 2228-2232
11. Chan CLH, Bokey EL, Chapuis PH, Renwick AA, Dent OF (2006) Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumor. Br J Surg 93: 105
12. Caricato M, Borsomati D, Valeri S, Rosignoli A, Coppola R (2005) Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 12: 21
13. D'Angelico M, Gonen M, Brennan F, Turnbull AD, Bains M, Karpeh MS (2004) Patterns of recurrence in completely resected gastric adenocarcinoma. Ann Surg 240: 808
14. Even-Sapir E, Parag Y, Lerman H et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232(3): 815-822
15. Flamen P, Lerut T, Haustermans K et al. (2004) Position of positron emission tomography and other imaging diagnostics modalities in esophageal cancer. Q J Nucl Mol Imaging 48(2): 96-108
16. Guillem JG, Chessin DB, Cohen AM et al. (2005) Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal Cancer. Ann Surg 241: 829
17. Hahnloser D, Nelson H, Gunderson LL et al. (2003) Curative Potential of Multimodal Therapy for Locally Recurrent Rectal Cancer. Ann Surg 237: 502
18. Hermanek P, Hermanek PJ (2002) Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 19: 329
19. Jatzko GR, Jagoditsch M, Lisborg PH, Denk H, Klimpfinger M, Stettner HM (1999) Long-term results of radical surgery for rectal cancer: multivariate analysis of prognostic factors influencing survival and local recurrence. Eur J Surg Oncol 25: 284
20. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638
21. Kato H, Miyazaki T, Nakajima M et al. (2004) Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br. J Surg 91(8): 1004-1009
22. Kessler H, Hermanek P (1998) Outcomes in rectal cancer surgery are directly related to technical factors. Semin Colon Rectal Surg 9: 247
23. Lehnert Th Golling M (2001) Posterior pelvic exenteration in locoregional recurrence of rectal carcinoma - indications, technique and outcome. Chirurg 72: 1393
24. Lerut T, Nafteux P, Moons J et al. (2004) Three field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, disease-free survival and ourtcome. Ann Surg 220 (6): 962-974
25. Lehnert T, Golling M, Buchholz J (2004) Lokoregionäres Rezidiv des Rektumkarzinoms. Chirurg 75: 38
26. Lordick F, Ott K, Weber WA et al. (2005) Individualized indication for neoadjuvant treatment based on metabolic rsponse assessed by 18.fluorodeoxy-glucose positron emission tomography (FDG-PET) in adenocarcinoma of the esophago-gastric junction (AEG). J Clin Oncol 23 [Suppl 16]: 318 (Abstr)
27. Luna-Perez P, Bustos-Cholico E, Alvarado I et al. (2005) Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low nanterior resection. J Surg Oncol 90: 20
28. Marks CG, Reid FDA, Lewis CE, Jackson PA, Cook MG (2000) What determines the outcome after total mesorectal excision for rectal carcinoma - 15 years experience of a specialist surgical unit. Colorectal Dis 2: 270
29. Motoyama S, Kitamura M, Saito R et al. (2006) Outcome and treatment strategy for mid-and lower thoracic esophageal cancer recurring locally in lymph nodes of the neck. World J Surg 30: 191-198
30. Nissan A, Guillem JG, Paty PB et al. (2001) Abdominoperineal resection for rectal cancer at a specialty center. Dis Colon Rectum 44: 27
31. Ott K, Fink U, Becker K et al. (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21: 4604
32. Porter GA, Soskolone CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227: 157
33. Saka M, Mudan S, Katai H et al. (2005) Pancreaticoduodenectomy for advanced gastric cancer. Gastric Cancer 8 (1): 1-5
34. Sauer R, Becker H, Hohenberger W et al. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N Engl J Med 351: 1731
35. Schmiegel W, Pox C, Adler G et al. (2004) S3- Leitlinienkonferenz"Kolorektales Karzinom" 2004. Z Gastroenterol 42: 1129
36. Secco GB, Ravera G, Bonfante P et al. (2001) Hepatogastroenterology 48: 1346
37. Selzner M, Hany TF, Wildbrett P et al. (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240(6): 1027-1035
38. Shibata D, Paty PB, Guillem JG et al. (2002) Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum 45: 795
39. Suzuki K, Dozois RR, Devine RM et al. (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39: 730
40. Weber WA, Ott K, Becker K et al. (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19: 3058
41. Wieder H, Brücher BLDM, Zimmermann F et al. (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22: 900